Interferons and Resistance Mechanisms in Tumors and Pathogen-Driven Diseases-Focus on the Major Histocompatibility Complex (MHC) Antigen Processing Pathway.

Massa, Chiara; Wang, Yuan; Marr, Nico; Seliger, Barbara

Massa, Chiara; Wang, Yuan; Marr, Nico; Seliger, Barbara.

Massa C; Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
Wang Y; Institute for Translational Immunology, Brandenburg Medical School Theodor Fontane, Hochstr. 29, 14770 Brandenburg an der Havel, Germany.
Marr N; Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 2, 06112 Halle, Germany.
Seliger B; Institute for Translational Immunology, Brandenburg Medical School Theodor Fontane, Hochstr. 29, 14770 Brandenburg an der Havel, Germany.

Int J Mol Sci ; 24(7)2023 Apr 04.

Article en En | MEDLINE | ID: mdl-37047709

Asunto(s)

COVID-19; Neoplasias; Humanos; Interferones/metabolismo; Presentación de Antígeno; COVID-19/genética; Complejo Mayor de Histocompatibilidad; Citocinas/genética; Antígenos de Histocompatibilidad Clase I/genética; Neoplasias/genética

Palabras clave

MHC class I; interferon; therapy; tumor

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article